Literature DB >> 18095591

[Expression of chemokine receptor CCR2 in cerebral tissue of newborn rat with experimental hypoxic-ischemic brain damage].

Xue Feng1, Yu-jia Yao.   

Abstract

OBJECTIVE: To observe the expressions of mRNA and protein for the CCR2 in cerebral tissue with experimental hypoxic-ischemic brain damage (HIBD) to newborn rat.
METHODS: The HIBD model of SD rat was set up by ligating the right carotid artery and exposing the animals to 8% oxygen for 2.5 h. The dynamic change of CCR2 mRNA level was studied by using quantitative, real-time, fluorescence PCR assay (TaqMan), and the change of CCR2 protein was detected by SDS-PAGE assay.
RESULTS: The highest expression of CCR2 mRNA was showing at 24 h after HIBD, of which the level was significantly higher in hypoxic-ischemic (HI) cerebral hemisphere than in control (P < 0.05). The CCR2 mRNA level of 72 h after HIBD was still higher than that of control (P > 0.05) but had no difference on 7 d after HIBD when compared with control (P > 0.05). The increased expression of CCR2 protein was detected at 12 h after HIBD and peaked at 24 h after HIBD. The significant increase of CCR2 protein persisted in HI hemisphere up to 3 d after HIBD.
CONCLUSION: The expressions of CCR2 mRNA and protein increase significantly in cerebral tissue of newborn rat with HIBD. The dynamic change of CCR2 expression is consistent with the process of HIBD, which suggests that CCR2 expression after HIBD may play an important role in the mechanism of brain damage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18095591

Source DB:  PubMed          Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-173X


  1 in total

1.  Overexpression of microRNA-381-3p ameliorates hypoxia/ischemia-induced neuronal damage and microglial inflammation via regulating the C-C chemokine receptor type 2 /nuclear transcription factor-kappa B axis.

Authors:  Yuanmei Che; Jianglong He; Xiaopeng Li; Daxian Wu; Yi Zhang; Guicai Yuan
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.